Citation only
via OpenAlex
Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease
Cora O’Neill, Aoife P. Kiely, Meghan F. Coakley, Sean Manning, Caitríona M. Long-Smith
Biochemical Society Transactions · 2012 · ▲ 139 citations
Abstract
The quality control of protein homoeostasis deteriorates with aging, causing the accumulation of misfolded proteins and neurodegeneration. Thus, in AD (Alzheimer's disease), soluble oligomers, protofibrils and fibrils of the Aβ (amyloid β-peptide) and tau protein accumulate in specific brain regions. This is associated with the progressive destruction of synaptic circuits controlling memory and higher mental function. The primary signalling mechanisms that (i) become defective in AD to alter the normal proteostasis(definition) of Aβ and tau, and (ii) initiate a pathophysiological response to cause cognitive decline, are unclear. The IIS [insulin/IGF-1 (insulin-like growth factor 1)-like signalling] pathway is mechanistically linked to longevity, protein homoeostasis, learning and memory, and is emerging to be central to both (i) and (ii). This pathway is aberrantly overactivated in AD brain at the level of increased activation of the serine/threonine kinase Akt and the phosphorylation of its downstream targets, including mTOR(definition) (mammalian target of rapamycin(definition)). Feedback inhibition of normal insulin/IGF activation of the pathway also occurs in AD due to inactivation of IRS-1 (insulin receptor substrate 1) and decreased IRS-1/2 levels. Pathogenic forms of Aβ may induce aberrant sustained activation of the PI3K (phosphoinositide 3-kinase)/Akt signal in AD, also causing non-responsive insulin and IGF-1 receptor, and altered tau phosphorylation, conformation and function. Reducing IIS activity in animal models by decreasing IGF-1R levels or inhibiting mTOR activity alters Aβ and tau protein homoeostasis towards less toxic protein conformations, improves cognitive function and extends healthy lifespan. Thus normalizing IIS dysfunction may be therapeutically relevant in abrogating Aβ and tau proteotoxicity, synaptic dysfunction and cognitive decline in AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1042/bst20120080
- Canonical
- link ↗
- Fetched
- 2026-08-27 MST
Cite this
APA
O’Neill, C., Kiely, A.P., Coakley, M.F., Manning, S., & Long-Smith, C.M. (2012). Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. <em>Biochemical Society Transactions</em>. https://doi.org/10.1042/bst20120080
Vancouver
O’Neill C, Kiely AP, Coakley MF, Manning S, Long-Smith CM. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. Biochemical Society Transactions. 2012. doi:10.1042/bst20120080.
BibTeX
@article{cora2012Insuli,
title = {Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease},
author = {Cora O’Neill and Aoife P. Kiely and Meghan F. Coakley and Sean Manning and Caitríona M. Long-Smith},
journal = {Biochemical Society Transactions},
year = {2012},
doi = {10.1042/bst20120080},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Communications Medicine 2025
Open access · CC-BY
Plasma-based brain age as a potential biomarker for cognitive health and risk of brain-related disorders
Free radical biology & medicine 2026
Citation only
Cyclophilin D (CypD) promotes mitochondrial impairment, synaptic defects, cognitive loss, and tau pathology during aging.
BioScience Trends 2023
Open access · OA
A circadian rhythm-restricted diet regulates autophagy to improve cognitive function and prolong lifespan
Biomolecules 2022
Open access · CC-BY
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Journal of Alzheimer s Disease 2017
Open access · OA
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Nature Communications 2024
Open access · CC-BY